Journal rankings · indicator year 2024
Choose a field to open its ranking, or a journal to find its row in its subfield’s list.
Subfield ranking · 2024
Rheumatology journal rankings 2024
67 ranked journals · Subfield in Medicine
Rheumatology has 67 ranked journals in 2024. The median OJR fell 0.07 on 2023 to 0.78, below the world average of 1.00; Q1 starts at OJR 1.44. The top three are Arthritis & Rheumatology, The Lancet Rheumatology, and Annals of the Rheumatic Diseases.
Ranks and citation indicators: 2024. Journal access status and listed APC: source snapshot September 23, 2026.
Journals whose main subfield sits in this category and that published at least 30 citable documents (articles, reviews and conference papers) in 2021–2023, the window the 2024 score is computed on.
The OpenJournalRank Indicator (OJR) is a free, publicly available metric of a journal’s field-normalized citation impact, computed from open OpenAlex citation data. It compares citations to a journal’s papers from the previous three years with the world average for papers of the same subfield, year and type, so 1.00 is the world average and values can be compared across fields. It is computed with the NCI3 method.
The middle OJR among ranked journals in this category: half score higher, half lower. 1.00 is the world average for papers of the same subfield, year and type.
The dot is this category, the solid tick is the median of all ranked journals and the dashed line is the world average.
Share of ranked journals in this category that are fully open access, so every paper is free to read. Hybrid journals, which sell subscriptions and open single papers for a fee, are not counted.
Median list price of the article processing charge, in US dollars, among ranked journals in this category that list a price above zero. Journals with a listed APC of $0 and journals with no known price are left out of this median. The At a glance table below gives a second median that includes the $0 prices.
Subfields of Medicine (42)
- Surgery980
- Pulmonary and Respiratory Medicine364
- Public Health, Environmental and Occupational Health316
- Cardiology and Cardiovascular Medicine289
- Infectious Diseases263
- Oncology243
- Epidemiology187
- Neurology175
- Radiology, Nuclear Medicine and Imaging161
- Physiology159
- Endocrinology, Diabetes and Metabolism157
- Psychiatry and Mental health144
- Rheumatology67
Show all 42 subfields
- Orthopedics and Sports Medicine125
- Ophthalmology100
- Pediatrics, Perinatology and Child Health100
- Dermatology92
- Obstetrics and Gynecology85
- Hematology83
- Nephrology65
- Complementary and alternative medicine59
- Reproductive Medicine52
- Pharmacology49
- Emergency Medicine42
- Geriatrics and Gerontology37
- Rehabilitation34
- Otorhinolaryngology33
- Hepatology30
- Pathology and Forensic Medicine29
- Immunology and Allergy26
- Critical Care and Intensive Care Medicine23
- Genetics19
- Anesthesiology and Pain Medicine14
- Urology12
- Health Informatics9
- Gastroenterology7
- Internal Medicine6
- Family Practice2
- Transplantation2
- Anatomy0
- Biochemistry0
- Microbiology0
67 ranked journals
Filters
Rank is the position by OJR within the list on screen; 1 is the highest. | OJR is field-normalized 3-year citation impact: 1.00 is the world average for papers of the same subfield, year and type, so values compare across fields. The badge is the journal’s quartile in this list. | Citations per paper over a two-year window, counted from OpenAlex. It is not field-normalized, so compare it only between journals of the same field. ▲ or ▼ is the change from 2023. This is OpenJournalRank’s own count, not Clarivate’s Journal Impact Factor. | Citable documents (articles, reviews and conference papers) published in 2021–2023, the window the 2024 OJR is computed on. A journal needs at least 30 to be ranked. | Share of the journal’s 2021–2023 papers that are free to read in any open-access form. The green OA tag next to a title marks a fully open-access journal. | List price of the article processing charge in US dollars. “$0 listed” means the listed price is zero; a dash means no price is listed. | The line is the journal’s OJR from 2015 to 2024. | Compare |
|---|---|---|---|---|---|---|---|
1Arthritis & RheumatologyWiley · United States | 2.76Q1 | 7.17 0.64 down from 2023 | 822 | 69% | $5,190 | ||
2The Lancet RheumatologyElsevier BV · United Kingdom | 2.72Q1 | 8.38 2.02 up from 2023 | 408 | 38% | $7,280 | ||
3Annals of the Rheumatic DiseasesBMJ · United Kingdom | 2.69Q1 | 8.38 0.94 up from 2023 | 1,346 | 5% | $4,870 | ||
4Best Practice & Research Clinical RheumatologyElsevier BV · Netherlands | 2.53Q1 | 5.59 0.31 up from 2023 | 145 | 52% | $4,180 | ||
5Autoimmunity ReviewsElsevier BV · Netherlands | 2.52Q1 | 8.04 0.04 down from 2023 | 454 | 44% | $4,730 | ||
6Nature Reviews RheumatologyNature Portfolio · United Kingdom | 2.48Q1 | 10.80 0.96 up from 2023 | 479 | 20% | — | ||
7Osteoarthritis and CartilageElsevier BV · United Kingdom | 2.48Q1 | 5.50 0.53 down from 2023 | 546 | 100% | $3,700 | ||
8Current Rheumatology ReportsSpringer Science+Business Media · United States | 2.14Q1 | 4.90 2.33 down from 2023 | 151 | 43% | $4,490 | ||
9Current Opinion in RheumatologyLippincott Williams & Wilkins · United States | 1.87Q1 | 4.59 0.53 down from 2023 | 177 | 28% | — | ||
10Arthritis Research & TherapyOABioMed Central · United Kingdom | 1.83Q1 | 5.10 0.15 up from 2023 | 799 | 100% | $3,690 | ||
11RMD OpenOABMJ · United Kingdom | 1.78Q1 | 5.00 0.61 down from 2023 | 684 | 100% | $2,391 | ||
12Lupus Science & MedicineOABMJ · United Kingdom | 1.72Q1 | 4.28 0.08 up from 2023 | 245 | 100% | $2,391 | ||
13Journal of Translational AutoimmunityOAElsevier BV · Netherlands | 1.67Q1 | 4.11 1.58 down from 2023 | 145 | 100% | $3,180 | ||
14Therapeutic Advances in Musculoskeletal DiseaseOASAGE Publishing · United Kingdom | 1.62Q1 | 4.75 0.77 up from 2023 | 266 | 100% | $2,650 | ||
15Arthritis Care & ResearchWiley · United States | 1.51Q1 | 3.53 0.51 down from 2023 | 578 | 78% | $4,640 | ||
16Rheumatic Disease Clinics of North AmericaElsevier BV · United States | 1.46Q1 | 3.50 0.72 up from 2023 | 162 | 15% | $3,500 | ||
17Seminars in Arthritis and RheumatismElsevier BV · United States | 1.44Q1 | 4.47 0.10 up from 2023 | 507 | 60% | $4,370 | ||
18Expert Review of Clinical ImmunologyTaylor & Francis · United Kingdom | 1.40Q2 | 3.89 0.43 down from 2023 | 363 | 25% | — | ||
19CartilageSAGE Publishing · United States | 1.34Q2 | 3.19 0.16 up from 2023 | 311 | 100% | $2,650 | ||
20Lara D. VeekenOxford University Press · United Kingdom | 1.30Q2 | 3.77 0.01 up from 2023 | 2,080 | 72% | $4,597 | ||
21Open Access Rheumatology Research and ReviewsOADove Medical Press · New Zealand | 1.25Q2 | 2.80 0.55 up from 2023 | 87 | 100% | $2,320 | ||
22Rheumatology and TherapyOAAdis, Springer Healthcare · United Kingdom | 1.18Q2 | 3.35 0.04 down from 2023 | 325 | 100% | $7,400 | ||
23European Cells and MaterialsOASwitzerland | 1.15Q2 | 3.24no change | 123 | 100% | $1,000 | ||
24Osteoarthritis and Cartilage OpenOAElsevier BV · United Kingdom | 1.13Q2 | 2.99 0.62 up from 2023 | 224 | 100% | $1,610 | ||
25Rheumatology InternationalSpringer Science+Business Media · Germany | 1.11Q2 | 3.29 0.63 down from 2023 | 742 | 49% | $4,990 | ||
26BMC RheumatologyOABioMed Central · United Kingdom | 1.09Q2 | 3.03 0.57 up from 2023 | 195 | 100% | $2,190 | ||
27Clinical RheumatologySpringer Science+Business Media · Belgium | 0.93Q2 | 2.71 0.29 down from 2023 | 1,254 | 33% | $4,890 | ||
28ACR Open RheumatologyOAWiley · United States | 0.93Q2 | 2.50 0.30 down from 2023 | 365 | 100% | $3,550 | ||
29Joint Bone SpineElsevier BV · France | 0.89Q2 | 2.50 0.16 up from 2023 | 464 | 47% | $3,020 | ||
30Rheumatology and Immunology ResearchOADe Gruyter · Poland | 0.87Q2 | 2.46 0.96 up from 2023 | 102 | 100% | $0 listed | ||
31LupusSAGE Publishing · United Kingdom | 0.84Q2 | 2.14 0.22 down from 2023 | 643 | 38% | $4,150 | ||
32Revista Brasileira de ReumatologiaOAElsevier BV · Brazil | 0.82Q2 | 2.51 0.10 up from 2023 | 173 | 100% | $2,490 | ||
33The Journal of RheumatologyThe Journal of Rheumatology Publishing Company Limited · Canada | 0.79Q2 | 2.22 0.02 up from 2023 | 736 | 96% | — | ||
34Connective Tissue ResearchTaylor & Francis · United Kingdom | 0.78Q2 | 2.18 0.33 down from 2023 | 108 | 44% | — | ||
35International Urogynecology JournalSpringer Science+Business Media · United Kingdom | 0.77Q3 | 2.03 0.14 down from 2023 | 974 | 37% | $3,790 | ||
36Musculoskeletal CareWiley · United Kingdom | 0.75Q3 | 1.84 0.11 down from 2023 | 294 | 78% | $3,240 | ||
37Modern RheumatologyOxford University Press · United States | 0.74Q3 | 2.11 0.16 up from 2023 | 469 | 59% | $3,208 | ||
38Reumatologia/RheumatologyOATermedia Publishing House · Poland | 0.72Q3 | 1.92 0.17 up from 2023 | 186 | 100% | — | ||
39Clinical Medicine Insights Arthritis and Musculoskeletal DisordersOASAGE Publishing · United Kingdom | 0.70Q3 | 2.28no change | 36 | 100% | $4,150 | ||
40JCR Journal of Clinical RheumatologyLippincott Williams & Wilkins · United States | 0.64Q3 | 1.74 0.05 up from 2023 | 282 | 21% | — | ||
41International Journal of Rheumatic DiseasesWiley · Australia | 0.60Q3 | 1.55 0.87 down from 2023 | 872 | 53% | $3,700 | ||
42European Journal of RheumatologyOAAVES Yayincilik · Türkiye | 0.59Q3 | 1.77 0.51 up from 2023 | 104 | 100% | — | ||
43Rheumatology Advances in PracticeOAOxford University Press · United Kingdom | 0.58Q3 | 1.54 0.14 down from 2023 | 326 | 100% | $2,974 | ||
44Mediterranean Journal of RheumatologyOAGreece | 0.56Q3 | 1.48 0.31 up from 2023 | 224 | 100% | — | ||
45Scandinavian Journal of RheumatologyTaylor & Francis · United Kingdom | 0.55Q3 | 1.44 0.42 down from 2023 | 267 | 60% | — | ||
46Archives of RheumatologyOATürkiye | 0.54Q3 | 1.12 0.12 down from 2023 | 223 | 100% | — | ||
47UrogynecologyLippincott Williams & Wilkins · United States | 0.50Q3 | 1.22 0.05 down from 2023 | 415 | 18% | — | ||
48Current Rheumatology ReviewsBentham Science Publishers · Netherlands | 0.48Q3 | 1.13 0.12 down from 2023 | 149 | 11% | — | ||
49ReumatismoOAPAGEPress (Italy) · Italy | 0.47Q3 | 1.10 0.72 down from 2023 | 99 | 100% | — | ||
50Journal of Cartilage & Joint PreservationOAElsevier BV · Netherlands | 0.46Q3 | 1.61 0.64 up from 2023 | 116 | 100% | $1,250 |
Subfields of Medicine, with Rheumatology highlighted.
- Surgery980
- Pulmonary and Respiratory Medicine364
- Public Health, Environmental and Occupational Health316
- Cardiology and Cardiovascular Medicine289
- Infectious Diseases263
- Oncology243
- Epidemiology187
- Neurology175
- Radiology, Nuclear Medicine and Imaging161
- Physiology159
- Endocrinology, Diabetes and Metabolism157
- Psychiatry and Mental health144
- Orthopedics and Sports Medicine125
- Ophthalmology100
- Pediatrics, Perinatology and Child Health100
- Dermatology92
- Obstetrics and Gynecology85
- Hematology83
- Rheumatology67
- Nephrology65
- Complementary and alternative medicine59
- Reproductive Medicine52
- Pharmacology49
- Emergency Medicine42
- Geriatrics and Gerontology37
- Rehabilitation34
- Otorhinolaryngology33
- Hepatology30
- Pathology and Forensic Medicine29
- Immunology and Allergy26
- Critical Care and Intensive Care Medicine23
- Genetics19
- Anesthesiology and Pain Medicine14
- Urology12
- Health Informatics9
- Gastroenterology7
- Internal Medicine6
- Family Practice2
- Transplantation2
- Anatomy0
- Biochemistry0
- Microbiology0
Journals
Citations made in 2024. Corpus-wide, 87.1% of core-journal articles and reviews published that year have at least one matched reference; the share varies by journal and field.
18 additional Rheumatology journals with metrics are unranked under this release’s eligibility rules: a journal needs at least 30 citable documents in 2021–2023, at least 80% of them with a subfield, and a positive world-average expectation. Ranks are within the whole category; filters hide rows without re-ranking. OJR excludes self-citations.
At a glance
Indicator year: 2024. Publication window: 2021–2023. How these summaries are calculated
- Ranked journals
- 67
- Window papers (baseline)
- 67,701 +8.3% from indicator year 2021
- Median OJR
- 0.785 -18.0% from indicator year 2021
- Rising journals (2025)
- 6
Window papers are the baseline paper population: citable papers (articles, reviews and conference papers) from 2021–2023 in all journals of the world-average baseline, including non-core journals, counted by each paper’s own subfield. They are not the papers of the ranked journals alone.
| Measure | Year series | 2000 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ranked journals | 20 | 24 | 25 | 27 | 30 | 32 | 37 | 38 | 38 | 39 | 43 | 49 | 53 | 56 | 59 | 58 | 58 | 65 | 65 | 67 | 69 | 67 | 65 | 67 | 67 | 70 | |
| Window papers (baseline) | 17,821 | 20,685 | 22,377 | 24,459 | 25,269 | 27,867 | 30,643 | 33,672 | 36,348 | 39,439 | 42,988 | 46,086 | 48,179 | 49,400 | 51,214 | 53,341 | 54,578 | 55,366 | 56,123 | 57,306 | 59,410 | 62,541 | 65,720 | 67,501 | 67,701 | 69,555 | |
| Median OJR | 0.91 | 0.782 | 0.862 | 0.81 | 0.884 | 1.05 | 0.855 | 0.803 | 0.92 | 0.891 | 0.7969 | 0.888 | 0.877 | 0.95 | 0.879 | 0.847 | 0.9574 | 0.889 | 0.873 | 0.93 | 0.99 | 0.9569 | 0.869 | 0.851 | 0.785 | 0.7970 |
How to read these rankings
- OJR, the OpenJournalRank Indicator
- A field-normalized 3-year citation impact, computed from OpenAlex with the NCI3 method. It divides the citations a journal’s papers received by the world average for papers of the same subfield, year and type, so 1.00 is the world average and 2.00 means twice as many citations as expected. Because it is normalized, it can be compared across fields. Read the methodology
- Quartiles
- Q1 to Q4 split the ranked journals of the list you are viewing into four equal groups by OJR. A journal’s quartile depends on the list: the same journal can be Q1 in its subfield and Q2 among all journals.
- Impact factor (2-year)
- Citations per paper over a two-year window, counted from OpenAlex. It is easy to compare with familiar impact factors but is not field-normalized, so compare it only within a field. It is not Clarivate’s Journal Impact Factor. Why it differs from the Journal Impact Factor
- Rank ranges
- Each rank in the latest year carries a likely range from 1,000 resamples of the journal’s papers. Where two journals’ ranges overlap, the data cannot tell them apart, so treat neighbouring ranks as ties.